StonvexLoading…
StonvexStonvexStonvexCore line items from EDBL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.81M | $13.86M | $14.05M | $11.55M |
Operating Income | $-15.80M | $-9.28M | $-9.87M | $-9.00M |
Net Income | $-17.33M | $-11.05M | $-10.19M | $-12.45M |
EPS (Diluted) | $-117.64 | $-685.62 | $-1541.79 | Not available |
Total Assets | $20.60M | $11.91M | $6.66M | $6.96M |
Total Liabilities | $8.10M | $7.82M | $6.94M | $9.14M |
Cash & Equivalents | $1.11M | $3.53M | $510.00K | $110.00K |
Free Cash Flow OCF − CapEx | $-12.44M | $-8.82M | $-9.55M | $-11.17M |
Shares Outstanding | 593.42K | 106.54K | 11.41K | 362.72K |